Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Intangibles (2020 - 2025)

Ascendis Pharma A's Intangibles history spans 2 years, with the latest figure at -$1.5 million for Q4 2023.

  • For Q4 2023, Intangibles fell 62.76% year-over-year to -$1.5 million; the TTM value through Dec 2023 reached -$1.5 million, down 62.76%, while the annual FY2023 figure was -$1.5 million, 58.4% down from the prior year.
  • Intangibles for Q4 2023 was -$1.5 million at Ascendis Pharma A, down from -$906999.9 in the prior quarter.
  • Across five years, Intangibles topped out at -$906999.9 in Q4 2022 and bottomed at -$1.5 million in Q4 2023.